Evado launches into Asia
Wednesday, 22 October, 2008
Melbourne company Evado has launched its clinical trial software into the growing south-east Asian market.
Evado is being distributed by local clinical research company SeerPharma.
Evado is a web-based mobile electronic data capture (EDC) system with two modules, one aimed at pre-clinical animal model trials and the other a clinical module for Phases I to IV.
It was developed in association with La Trobe University software researchers working at the university’s Microsoft Centre, along with Intel.
Evado CEO Jennie Anderson said the software was designed so that researchers can collect data on larger screens in a format similar to paper-based clinical research forms.
Shorter radiotherapy course proves safe for prostate cancer
A significantly shorter course of radiotherapy for localised prostate cancer is just as safe and...
5-in-1 meningococcal vaccine proves effective
A life-saving meningococcal vaccine covering all five common strains of the deadly disease could...
Diabetes drug reduces knee arthritis pain in overweight patients
A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or...